Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Cristina Carraro
Nilotinib Interferes With Cell Cycle, ABC Transporters and JAK-STAT Signaling Pathway in CD34+/lin- Cells of Patients With Chronic Phase Chronic Myeloid Leukemia After 12 Months of Treatment
PLoS ONE
Multidisciplinary
Related publications
Satisfaction With Information on Nilotinib Treatment in Chronic Myeloid Leukemia Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Pancreatic Enzyme Elevation in Chronic Myeloid Leukemia Patients Treated With Nilotinib After Imatinib Failure
Haematologica
Hematology
In Vitro Effects of Imatinib on CD34+ Cells of Patients With Chronic Myeloid Leukemia in the Megakaryocytic Crisis Phase
Oncology Letters
Cancer Research
Oncology
Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib
Hematology Reports
Hematology
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nilotinib vs Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 3-Year Follow-Up
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy
Experimental Oncology
Cancer Research
Oncology
The Long Noncoding RNA MEG3 and Its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology